At present, the most investigated one is PD-L1, the expression of which changes in response to chemotherapy in solid tumors such as in urothelial carcinoma treated with cisplatin/carboplatin and paclitaxel or in human adenocarcinoma and hepatocellular cell lines [39,40]. Here, CD274 is linked to adenocarcinoma.